Eye Care Blog | LASIK Surgery Arlington | See Clearly Vision

Blog

Corneal Cross Linking Surgery

Top 10 Questions about Corneal Cross-Linking

Keratoconus is one of the most common corneal disorders in the U.S. today. In 2016, the FDA approved the corneal cross-linking procedure for progressive keratoconus and corneal ectasia after refractive eye surgery. Our very own Dr. Dawn Williams wrote an article in Optometry Times answering the top 10 frequently asked questions about corneal cross-linking:


Raindrop in the Cornea

Introducing Raindrop® Near Vision Inlay, a Simple Solution for Near Vision Loss

Raindrop Vision Procedure Designed for People Who Want to Reduce or Eliminate Reading Glasses Now Available at See Clearly Vision The all-new Raindrop ® Near Vision Inlay is designed to improve near vision so you can see fine print, menus and your phone without the hassle of reading glasses Tysons, July 31, 2017 — If… Read More


Tales from Los Angeles

Tales from Los Angeles

During the first weekend in May, a very important event took place in Tinseltown. It wasn’t a movie premiere or a celebrity plugging their latest product. In fact, it was much more exciting! The annual American Society of Cataract and Refractive Surgery (ASCRS) meeting took place in Los Angeles. While there, our very own Dr…. Read More


TrueTear™ – The New Dry Eye Therapy

TrueTear™ – The New Dry Eye Therapy

Do you have dry eye issues? TrueTear™ could be the product for you! We are excited to be the first practice in Northern Virginia to offer TrueTear™ by Allergan. TrueTear™ is an intranasal neurostimulating device that helps increase tear production for those suffering with dry eyes without having to apply eye drops or artificial tears…. Read More


avedro Logo

First FDA Approved Cross-Linking Procedures Are Performed on Patients in the U.S. with Progressive Keratoconus

Sept. 28, 2016 04:01 UTC First FDA Approved Cross-Linking Procedures Are Performed on Patients in the U.S. with Progressive Keratoconus Avedro Shipping Photrexa® Viscous and Photrexa® to Ophthalmologists Nationwide WALTHAM, Mass.–(BUSINESS WIRE)– Avedro, Inc., an ophthalmic pharmaceutical and medical device company, is now shipping Photrexa Viscous and Photrexa, the drugs used in corneal cross-linking procedures… Read More


Dr. Rajesh K. Rajpal KXL treatment

First patient to have Collagen Cross-Linking after FDA approval

First patient to have Collagen Cross-Linking after FDA approval with Dr. Rajesh Rajpal. Congratulations to Dr. Rajpal and the staff at See Clearly Vision!


What you should know about swimming and your eyes

What you should know about swimming and your eyes

Whether you enjoy a leisurely dip in a hotel pool or compete in the Olympic 200 meter freestyle, you may be familiar with the stinging, burning and redness of “swimmer’s eye.” While swimming is a great form of exercise and a relaxing way to cool down, it can be hard on your eyes… Read More… Read More


New Collagen Cross-Linking Indication in US

New Collagen Cross-Linking Indication in US

In this edition of EyewireTV, Dr. Rajesh Rajpal discusses the recent FDA approval for a second indication of Collagen Cross-Linking for the treatment of Corneal Ectasia following Refractive Surgery. For further information and to watch the video, please visit: EyeWireTV


Avedro Plots Future of Corneal Cross-Linking

Avedro Plots Future of Corneal Cross-Linking

Just about two weeks after getting Food and Drug Administration (FDA) clearance for its corneal crosslinking platform, Avedro Chief Medical Officer Rajesh K. Raipal, MD, outlined the company’s next steps to advance its position in the crosslinking space during the Ophthalmology Innovations Showcase at OIS@ASCRS 2016. OIS.net


What you need to know about Corneal Collagen Cross-Linking

What you need to know about Corneal Collagen Cross-Linking

April 18th, 2016 was a life-changing day for people living with keratoconus in the USA; corneal collagen crosslinking, the revolutionary treatment that’s been performed in Europe since 1999, was finally approved by the FDA. Keratoconus affects as many as 1 in every 500 people, causing potentially severe vision loss. But it’s progression and causes are… Read More


Our Locations

Tysons Corner

Location:

8138 Watson St
McLean, VA 22102

Phone Number:

703-827-5454

OFFICE HOURS:

Monday through Friday
8:30 am to 5:00 pm

Arlington

Location:

1715 N. George Mason Drive
Suite 206
Arlington, VA 22205

Phone Number:

703-525-4411

OFFICE HOURS:

Monday through Friday
8:30 am to 5:00 pm

Rockville

Location:

5842 Hubbard Drive
Rockville, MD 20852

Phone Number:

301-770-6888

OFFICE HOURS:

Hours: Monday 8:30 - 12:00 Tuesday closed
Wednesday 8:30 - 12:00
Thursday 8:30- 5:00
Friday closed.

Contact Us

Top Doc 19Top Doc 2019Top Doc 2020Top Doc 2020Top Doctors 2018 - 2020Top Doctors 2020 - 2021Premier Surgeon
(877) 234-2020
Schedule an Appointment
contact us
pay online
patient portal
read our reviews
FacebookYouTubeTwitterinstagram